FARS2 deficiency increased the cardiomyocyte cross-sectional area and cardiac hypertrophy, whereas AAV-Drp1i and AAV-Mfn1 mitigated these changes (Figure 7E and 7F). The gene discussed is MFN1; the disease is cardiac hypertrophy.